EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Very High‐Power Short‐Duration Ablation for Atrial Fibrillation in Adults With Congenital Heart Disease

Sarah Lengauer, Nico Erhard iD, Miruna A Popa iD, Marta Telishevska, Hannah Krafft, Fabian Bahlke iD, Florian Englert, Felix Bourier iD, Tilko Reents, Isabel Deisenhofer iD, Gabriele Hessling

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.16567 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Sarah Lengauer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, German Heart Center Munich, TUM University Hospital, Munich, Bavaria, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Heart Defects, Congenital. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Data regarding safety and long‐term outcome of very high‐power‐short duration (vHPSD) ablation in adult congenital heart disease (ACHD) patients with paroxysmal or persistent atrial fibrillation (AF) are lacking.

Methods

Retrospective observational single‐center study. The data of 66 consecutive ACHD patients (mean age 60 ± 12.8 years, 46% male) with mild (69.7%), moderate (22.7%), or complex (7.6%) congenital heart disease (CHD) who underwent ablation for paroxysmal (40.9%) or persistent AF (59.1%) were analyzed. Circumferential PVI was performed in all patients and additional substrate ablation in 79,4% of persistent AF patients using irrigated RF energy with vHPSD settings of 70 W/5–7 s or 60 W/7–10 s.

Results

Mean procedure time was 123.6 ± 42 min with a mean RF time of 18.19 ± 10 min. No technique related adverse events occurred. Vascular access complications were detected in seven patients (10.6%) requiring intervention in four patients (6%). A median follow‐up time of 491 days (IQR: 194–1054 days). Freedom from any atrial arrhythmia off antiarrhythmic drugs (AAD) at 1 year was present in 58% of patients (77.8% with paroxysmal AF, 43.6% with persistent AF). Conclusion vHPSD for ablation of paroxysmal or persistent AF in ACHD patients is safe and effective. Regardless of CHD complexity, no vHPSD ablation modality related complications occurred. Long‐term outcome for paroxysmal AF after one ablation was excellent whereas results for persistent AF were limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHeart Defects, CongenitalAgedFemaleHumansMaleMiddle AgedAction PotentialsHeart RateProgression-Free SurvivalRecurrenceRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

adults with congenital heart diseaselong‐term outcomeparoxysmal and persistent atrial fibrillationsafetyvery high‐power short duration ablation

Autor:innen und Institutionen

  • Department of Electrophysiology, German Heart Center Munich, TUM University Hospital, Munich, Bavaria, Germany.

ORCID-Profile: Nico Erhard, Miruna A Popa, Fabian Bahlke, Felix Bourier, Isabel Deisenhofer

Zitieren

APA

Lengauer, S., Erhard, N., Popa, M. A., Telishevska, M., Krafft, H., Bahlke, F., Englert, F., Bourier, F., Reents, T., Deisenhofer, I., & Hessling, G. (2025). Very High‐Power Short‐Duration Ablation for Atrial Fibrillation in Adults With Congenital Heart Disease. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16567

Vancouver

Lengauer S, Erhard N, Popa MA, Telishevska M, Krafft H, Bahlke F, et al. Very High‐Power Short‐Duration Ablation for Atrial Fibrillation in Adults With Congenital Heart Disease. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16567

BibTeX
@article{Lengauer2025,
  author = {Lengauer, Sarah and Erhard, Nico and Popa, Miruna A and Telishevska, Marta and Krafft, Hannah and Bahlke, Fabian and Englert, Florian and Bourier, Felix and Reents, Tilko and Deisenhofer, Isabel and Hessling, Gabriele},
  title = {Very High‐Power Short‐Duration Ablation for Atrial Fibrillation in Adults With Congenital Heart Disease},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.16567}
}
Kostenlos starten →